The London Biotechnology Show 2025, held from 18 to 19 June, encompassed a range of sessions on automation, regulation, and ...

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Novartis has completed its previously announced acquisition of Regulus Therapeutics for $1.7bn, strengthening its renal ...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.

The evolving landscape of vaccine oversight makes it key to maintain public trust and keep scientific integrity at the ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

The US FDA has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five years and above with active lupus ...

Discover why leaders in the pharmaceutical industry are investing in future-ready, smart digital strategies for process ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.